**Due to vial size limitations, Tiers 1, 2 and 3 plans will receive the same total mg, but will have different dosing instructions
Many patients prefer the outer thigh because it remains visible during self-injection, allowing for accurate site assessment and needle angle verification
One year after starting semaglutide, 37.4% of patients taking the drug for obesity lost 10% or more of their body weight, while only 16.6% of those taking it for Type 2 diabetes lost this much weight
Statements Author contributions RT-T: Conceptualization, Writing original draft, Writing review & editing
Semaglutide injections sometimes develop visible bubbles in the pen or syringe, which can trigger worry about medication safety or effectiveness